Alissa Visram - Publications, H-index & Citations

Back

Alissa Visram

mcmaster university

18H-index

129Paper Count

809Citation Count

Published Papers 47

Publication Date

High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients

British Journal of Haematology

IF3.8

2026-08-21

PREAI

Y. Lisa Hwa; Dragan Jevremovic; Karen Pak; Prashant Kapoor; Alissa Visram; Morie A. Gertz; David D. Dingli; Francis K. Buadi; Ronald S. Go; Rahma Warsame; Nelson Leung; Wilson I. Gonsalves; Miriam A. Hobbs; Amie L. Fonder; Joselle M. Cook; Moritz Binder; Suzanne R. Hayman; Taxiarchis Kourelis; S. Vincent Rajkumar; Angela Dispenzieri; Shaji K. Kumar; Eli Muchtar

Save

Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders

Blood Cancer Journal

IF11.6

2026-03-26

OAAI

Koo, Edward; Albert, Sarah; Patrick, Benjamin; Henia, Meriem; Rhiwi, Yona; McCudden, Christopher; Jimenez Zepeda, Victor; Sandhu, Irwindeep; Chu, Michael; Mian, Hira; Visram, Alissa

Save

Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis

Blood Advances

IF7.1

2026-02-26

OAAI

Carlyn Rose Tan; Saad Usmani; Andriy Derkach; Andre de Meneze Silva Corraes; Ricardo Parrondo; Sikander Ailawadhi; Sireesha Asoori; Mrugakshi Dave; Rakesh Popat; Oliver Morjaria; Roman Hajek; Jana Mihalyova; Myo Htut; Murali Janakiram; Alissa Visram; Efstathios Kastritis; Meletios A. Dimopoulos; Joaquin Martinez-Lopez; Chandramouli Nagarajan; Susan Bal

Save

Anti-BCMA-CAR-IL15 natural killer cells prevent multiple myeloma growth in the bone marrow but allow subsequent emergence of extramedullary disease

Cancer Letters

IF10.1

2025-12-24

OAAI

Shelby Kaczmarek; Donghyeon Jo; Safa Ghaziasgar; Bryan Marr; Stefania Berton; Lisheng Wang; Mehdi Arbabi Ghahroudi; Mihue Jang; Alissa Visram; Scott McComb; Seung-Hwan Lee

Save

Real world comparison of progression free survival and time to next therapy in 761 newly diagnosed multiple myeloma patients

Blood Advances

IF7.1

2025-12-22

OAAI

Hira Mian; Mariano Arribas; Rafael Fonseca; Erin Mutterback; Omar Shahid; Rohan Gouda; Gregory R. Pond; Alissa Visram

Save

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials

JNCI: Journal of the National Cancer Institute

IF0

2025-11-09

OAAI

Maria Mainou, MD; Muatassem Alsadhan, MD; Kalliopi Tsapa, MD; Alissa Visram, MD; Hira Mian, MD; Rakesh Popat, MD; Elias K Mai, MD; Rajshekhar Chakraborty, MD; Samer Al Hadidi, MD; Meera Mohan, MD; Aniko Szabo, PhD; Oliver Van Oekelen, MD; Edward R Scheffer Cliff, MBBS; Ghulam Rehman Mohyuddin, MD

Save

Changes in Frailty Categorization Over One Year among Real-World Patients with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-09-11

PREAI

Imran Haider; Darryl P. Leong; Omar Shahid; Martha Louzada; Arleigh McCurdy; Gregory R. Pond; Ruthanne Cameron; Amaris K Balitsky; Joanne Britto; Mohammed Aljama; Alissa Visram; Tanya M. Wildes; Hira Mian

Save

Real-World Outcomes of Transplant Ineligible Older Adults With Multiple Myeloma Treated With Novel Regimens: A Population-Based Retrospective Cohort Study

American Journal of Hematology

IF9.9

2025-08-29

PREAI

Nadine Abdallah; Hira Mian; Hsien Seow; Gregory P. Pond; Anastasia Gayowsky; Alissa Visram; Luciano J. Costa; Tanya M. Wildes; Rafael Fonseca; Charlotte Pawlyn; Gordon Cook; Shaji Kumar; Rajshekhar Chakraborty

Save

Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study

Blood Cancer Journal

IF11.6

2025-08-29

OAAI

Adrian Wong; Victor H. Jimenez-Zepeda; Kathryn Rankin; Irwin Sandhu; Michael Chu; Aurélien Delluc; Hira Mian; Julie Stakiw; Christopher Cipkar; Arleigh McCurdy; Benjamin Patrick; Sarah Albert; Meriem Henia; Edward Koo; Hyra Sapru; Christopher McCudden; Alissa Visram

Save

CAR-NK cells to treat patients with cancer: a systematic scoping review of published studies and registered clinical trials

Cytotherapy

IF3.2

2025-06-13

OAAI

Simrit Rana; Lilli Thomas; Aidan M. Kirkham; Risa Shorr; Alissa Visram; Harinad Maganti; Matthew Seftel; David S. Allan

Save

Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expression

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-03-07

OAAI

Jo, Dong-Hyeon; Kaczmarek, Shelby; Khan, Abrar Ul Haq; Pervin, Jannat; Clark, Diana M.; Gadde, Suresh; Wang, Lisheng; Mccomb, Scott; Visram, Alissa; Lee, Seung-Hwan

Save

Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studies

CYTOTHERAPY

IF3.2

2025-03-01

PREAI

Bastin, Donald J.; Kilgour, Marisa K.; Shorr, Risa; Delluc, Aurelien; Sabri, Elham; Ardolino, Michele; Mccomb, Scott; Lee, Seung-Hwan; Allan, David; Ramsay, Tim; Visram, Alissa

Save

First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline Consortium

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

IF2.7

2025-03-01

OAAI

Khan, Sahar; Bergstrom, Debra J.; Cote, Julie; Kotb, Rami; Leblanc, Richard; Louzada, Martha L.; Mian, Hira S.; Othman, Ibraheem; Colasurdo, Gabriele; Visram, Alissa

Save

Treatment of elderly and frail myeloma patients

PRESSE MEDICALE

IF3.4

2025-03-01

OAAI

Shih, Steven Chun-Min; Visram, Alissa; Mian, Hira

Save

Hypercalcemia in MGUS: keep the differential diagnosis broad

BLOOD

IF23.1

2025-02-27

PREAI

Mian, H; Visram, A

Save

Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis

BLOOD ADVANCES

IF7.1

2024-11-27

OAAI

Ebraheem, Mohammad S.; Chakraborty, Rajshekhar; Rochwerg, Bram; Visram, Alissa; Mohyuddin, Ghulam Rehman; Venner, Christopher P.; Sandhu, Irwindeep; Mccurdy, Arleigh; Facon, Thierry; Mateos, Maria-Victoria; Mian, Hira

Save

Impact of age on treatment utilization for newly diagnosed multiple myeloma: a nationwide retrospective cohort study

BLOOD CANCER JOURNAL

IF11.6

2024-10-16

OAAI

Mohyuddin, Ghulam Rehman; Mian, Hira; Gayowsky, Anastasia; Seow, Hsien; Chakraborty, Rajshekhar; Pond, Gregory R.; Al Hadidi, Samer; Visram, Alissa

Save

Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma

BLOOD CANCER JOURNAL

IF11.6

2024-10-14

OAAI

Werly, Annika; Hampel, Mareike; Hielscher, Thomas; Zuern, Kosima; Schmidt, Sophia K.; Visram, Alissa; Raab, Marc S.; Mueller-Tidow, Carsten; Goldschmidt, Hartmut; Mai, Elias K.

Save

Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study

HAEMATOLOGICA

IF7.9

2024-08-22

OAAI

Visram, Alissa; Chan, Kelvin Kar-Wing; Seow, Hsien; Pond, Gregory; Gayowsky, Anastasia; Mohyuddin, Ghulam Rehman; Mccurdy, Arleigh; Sandhu, Irwindeep; Venner, Christopher; Lancman, Guido; Balitsky, Amaris; Kouroukis, Tom; Bruins, Robert; Kumar, Shaji; Fonseca, Rafael; Mian, Hira

Save

Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100 (vol 36, pg 1429, 2022)

LEUKEMIA

IF13.4

2024-07-02

PREAI

Visram, Alissa; Rajkumar, S. Vincent; Kapoor, Prashant; Dispenzieri, Angela; Lacy, Martha Q.; Gertz, Morie A.; Buadi, Francis K.; Hayman, Suzanne R.; Dingli, David; Kourelis, Taxiarchis; Gonsalves, Wilson; Warsame, Rahma; Muchtar, Eli; Leung, Nelson; Kyle, Robert A.; Kumar, Shaji K.

Save

Research Directions